診療ガイドラインのためのGRADEシステム　第3版

出版社： 中外医学社
著者：
発行日： 2018-12-25
分野： 医学一般  >  医学概論
ISBN： 9784498014060
電子書籍版： 2018-12-25 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

13,200 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

13,200 円(税込)

購入する

商品紹介

日本国内でもMinds（日本医療機能評価機構の利用情報サービス）が国内診療ガイドライン作成システムとしてGRADEシステムを正式に採用し，GRADEシステムを使った診療ガイドラインの作成は急増している．その最新の内容を日本語で学べる唯一無二の著書が満を持して登場した．診療ガイドライン作成に，必要な知識のすべてがここに！

目次

  • Part 1●診療ガイドラインとGRADEシステム
    　1.1　診療ガイドラインとは
    　1.2　診療ガイドライン作成のプロセス

    Part 2●‌シナリオを使ったGRADEシステムの手順：エビデンスから推奨へ
    　2.1　シナリオ
    　2.2　エビデンスの検索・収集と統合
    　2.3　各アウトカムのエビデンスの確実性評価
    　2.4　エビデンスから推奨へ（完全コンテキスト化アプローチ）
    　2.5　シナリオのEvidence to Decision（EtD）テーブルと推奨の提示

    Part 3●予後研究へのGRADEシステムの適用
    　3.1　予後研究
    　3.2　なぜ予後（ベースラインリスク）のエビデンスが必要なのか
    　3.3　予後（ベースラインリスク）のエビデンスの確実性
    　3.4　予後研究（ベースラインリスク）に関するエビデンスプロファイル

    Part 4●‌質的研究統合へのGRADEシステムの適用：CERQual
    　4.1　質的研究と診療ガイドライン
    　4.2　質的メタ統合とそのステップ
    　4.3　質的エビデンス統合をいつ使えるのか
    　4.4　CERQual アプローチ
    　4.5　質的研究およびCERQualにおける用語の定義

    Part 5●‌‌ネットワークメタアナリシスへのGRADEシステムの適用
    　5.1　ネットワークにおける直接比較と間接比較、およびループ
    　5.2　ネットワークエビデンスへのGRADEシステム適用の進歩
    　5.3　ネットワーク推定値のGRADE評価プロセスの手順
    　5.4　NMAの各推定値のGRADE評価例
    　5.5　ランキング（ranking）の評価
    　5.6　NMAの解析法
    　5.7　NMAで使用される専門用語

    Part 6●‌診断検査精度へのGRADEシステムの適用
    　6.1　診断検査に関する推奨の作成とGRADEシステム
    　6.2　診断検査・戦略の目的と役割
    　6.3　診断検査精度の評価方法とアウトカム
    　6.4　診断検査・戦略に関する疑問の定式化
    　6.5　診断検査精度のエビデンス
    　6.6　診断検査精度のエビデンステーブル
    　6.7　診断検査精度のエビデンスから推奨作成
    　6.8　診断検査・戦略に関する推奨作成例

    Part 7●追加資料
    　1.　‌信頼できる診療ガイドライン作成の基準（IOM）
    　2.　‌システマティックレビューのための基準（IOM）
    　3.　‌利益関係の宣言と利益相反の管理のためのG-I-N方針
    　4.　PRISMA声明とチェックリスト
    　5.　AMSTARチェックリスト
    　6.　GRADEpro GDTの利用法
    　7.　Evidence to Decisionフレームワーク
    　8.　推奨作成における合意形成法
    　9.　2×2テーブル
    　10.　診断研究のメタアナリシス
    　11.　GRADEワークショップ資料：治療介入
    　12.　GRADEワークショップ資料：診断研究
    　13.　GIN-McMaster ガイドライン作成チェックリスト
    　14.　オンライン資料

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

Part 7 追加資料

P.399 掲載の参考文献
1 Fretheim A, Schunemann H, Oxman A. Improving the use of research evidence in guideline development : 3. Group composition and consultation process. Health Research Policy and Systems. 2006 ; 4 (1) : 15.
PubMed
2 Kunz R, Fretheim A, Cluzeau F, et al. Guideline Group Composition and Group Processes : Article 3 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 229-233.
 
3 The ADAPTE Collaboration. The ADAPTE Process : Resource Toolkit for Guideline Adaptation. Version 2.0. 2009 ; http://www.g-i-n.net/document-store/working-groups-documents/adaptation/adapteresource-toolkit-guideline-adaptation-2-0.pdf. Accessed July 5, 2013.
 
4 World Health Organization. Estonian Handbook for Guidelines Development. 2011 ; http://whqlibdoc.who.int/publications/2011/9789241502429_eng.pdf. Accessed April 22, 2013.
 
5 National Institute for Health and Clinical Excellence. The guidelines manual. 2012 ; http://www.nice.org.uk/article/PMG6/chapter/1%20Introduction. Accessed April 22, 2013.
 
6 Scottish Intercollegiate Guidelines Network. SIGN 50 : A guideline developer's handbook. 2011 ; http://www.sign.ac.uk/guidelines/fulltext/50/. Accessed April 22, 2013.
 
7 World Health Organization. WHO Handbook for Guideline Development. 2012 ; http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf. Accessed April 22, 2013.
 
8 American College of Cardiology Foundation and American Heart Association. Methodology Manual and Policies from the ACCF/AHA Task Force on Practice Guidelines. 2010 ; http://my.americanheart.org/professional/StatementsGuidelines/PoliciesDevelopment/Development/Methodologies-and-Policiesfrom-the-ACCAHA-Task-Force-on-Practice-Guidelines_UCM_320470_Article.jsp. Accessed April 22, 2013.
 
9 Rosenfeld RM, Shiffman RN, Robertson P. Clinical Practice Guideline Development Manual, Third Edition : A Quality-Driven Approach for Translating Evidence into Action. Otolaryngology-Head and Neck Surgery. 2013 ; 148 (1 suppl) : S1-S55.
 
10 Cancer Care Ontario. Program in Evidence-Based Care Handbook. 2012 ; http://www.cancercare.on.ca/about/programs/pebc/pebc-products/. Accessed April 22, 2013.
 
11 Centers for Disease Control and Prevention. Guidelines and Recommendations : A CDC Primer. Atlanta, Georgia : Office of the Associate Director for Science Centers for Disease Control and Prevention ; 2012.
 
12 Davino-Ramaya C, Krause LK, Robbins CW, et al. Transparency matters : Kaiser Permanente's National Guideline Program methodological processes. The Permanente journal. Winter 2012 ; 16 (1) : 55-62.
 
13 Canadian Task Force on Preventive Health Care. Canadian Task Force on Preventive Health Care Procedure Manual. 2011 ; http://canadiantaskforce.ca/methods/methods-manual/. Accessed April 22, 2013.
 
14 Gutierrez GC, Bossert T, Espinosa JQ, et al. Guia Metodologica para la elaboracion de Guias de Atencion Integral en el Sistema General de Seguridad Social en Salud Colombiano. 2010 ; http://www.minsalud.gov.co/Documentos%20y%20Publicaciones/GUIA%20METODOLOGICA%20PARA%20LA%20ELABORACI%C3%93N%20DE%20GU%C3%8DAS%20DE%20ATENCI%C3%93N%20INTEGRAL.pdf. Accessed April 22, 2013.
 
15 Ministerio de Sanidad y Consumo. Elaboracion de guias de practica clinica en el sistema nacional de salud : Manual metodologico. 2007 ; http://www.guiasalud.es/emanuales/elaboracion/index-02.html. Accessed April 22, 2013.
 
16 German Association of the Scientific Medical Societies (AWMF) -Standing Guidelines Commission. AWMF Guidance Manual and Rules for Guideline Development, 1st Edition, English Version. 2012 ; http://www.awmf.org/leitlinien/awmf-regelwerk/awmf-guidance.html. Accessed May 2, 2014.
 
17 Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development : 2. Priority setting. Health Research Policy and Systems. 2006 ; 4 (1) : 14.
PubMed
18 American College of Cardiology Foundation and American Heart Association. Manuscript Development Process. 2010 ; http://my.americanheart.org/professional/StatementsGuidelines/PoliciesDevelopment/Policies-Development_UCM_316897_Article.jsp. Accessed April 22, 2013.
 
19 New Zealand Guidelines Group. Handbook for the preparation of explicit evidence-based clinical practice guidelines. Wellington : New Zealand Guidelines Group ; 2001.
 
20 Agency for Healthcare Research and Quality. U. S. Preventive Services Task Force Procedure Manual. 2008 ; http://www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual.htm. Accessed April 22, 2013.
 
21 National Health and Medical Research Council. Procedures and requirements for meeting the 2011 NHMRC standard for clinical practice guidelines. 2011 ; http://www.nhmrc.gov.au/guidelines/publications/cp133-and-cp133a. Accessed April 22, 2013.
 
22 Ministerio de Salud. Norma tecnica para la elaboracion de guias de practica clinica. 2005 ; http://bvs.minsa.gob.pe/local/MINSA/1176_DGSP196.pdf. Accessed April 22, 2013.
 
23 Qaseem A, Forland F, Macbeth F, Ollenschlager G, Phillips S, van der Wees P. Guidelines International Network : Toward international standards for clinical practice guidelines. Ann Intern Med. 2012 ; 156 (7) : 525-531.
PubMed
24 Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust. 2011 ; http://www.nap.edu/openbook.php?record_id=13058. Accessed April 22, 2013.
 
25 European Society of Cardiology. Recommendations for Guidelines Production. 2010 ; http://www.escardio.org/guidelines-surveys/esc-guidelines/about/Pages/rules-writing.aspx. Accessed April 22, 2013.
 
26 Boyd EA, Akl EA, Baumann M, et al. Guideline Funding and Conflicts of Interest : Article 4 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 234-242.
PubMed
27 Brouwers MC, Kho ME, Browman GP, et al. AGREE II : Advancing guideline development, reporting and evaluation in health care. Canadian Medical Association Journal. 2010 ; 182 (18) : E839-E842.
 
28 Schunemann H, Fretheim A, Oxman A. Improving the use of research evidence in guideline development : 1. Guidelines for guidelines. Health Research Policy and Systems. 2006 ; 4 (1) : 13.
PubMed
29 National Institute for Health and Clinical Excellence. How NICE clinical guidelines are developed : An overview for stakeholders, the public and the NHS. 5th Edition. 2012 ; http://publications.nice.org.uk/pmg6f. Accessed April 22, 2013.
 
30 Jacobs AK, Kushner FG, Ettinger SM, et al. ACCF/AHA clinical practice guideline methodology summit report : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 ; 61 (2) : 213-265.
 
31 Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development : 12. Incorporating considerations of equity. Health Research Policy and Systems. 2006 ; 4 (1) : 24.
 
32 Cluzeau F, Wedzicha JA, Kelson M, et al. Stakeholder Involvement : How to Do It Right : Article 9 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 269-273.
 
33 Fretheim A, Schunemann H, Oxman A. Improving the use of research evidence in guideline development : 5. Group processes. Health Research Policy and Systems. 2006 ; 4 (1) : 17.
PubMed
34 Wilt TJ, Guyatt G, Kunz R, et al. Deciding What Type of Evidence and Outcomes to Include in Guidelines : Article 5 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 243-250.
PubMed
35 Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines : a proposal from the Conference on Guideline Standardization. Ann Intern Med. 2003 ; 139 (6) : 493-498.
PubMed
36 Atkins D, Perez-Padilla R, MacNee W, Buist AS, Cruz AA. Priority Setting in Guideline Development : Article 2 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 225-228.
PubMed
37 Eccles M, Grimshaw J, Shekelle P, Schunemann H, Woolf S. Developing clinical practice guidelines : target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest. Implementation Science. 2012 ; 7 (1) : 60.
 
38 Akl EA, Treweek S, Foy R, Francis J, Oxman AD, Re Bg. NorthStar, a support tool for the design and evaluation of quality improvement interventions in healthcare. Implement Sci. 2007 ; 2 : 19.
 
39 Burgers JS, Anzueto A, Black PN, et al. Adaptation, Evaluation, and Updating of Guidelines : Article 14 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 304-310.
PubMed
40 Esandi ME, Luca MD, Chapman E, Schapochnik N, Bernztein R, Otheguy L. Guia para la adaptacion de Guoas de Practica Clinica. 2008 ; http://publicaciones.ops.org.ar/publicaciones/otras%20pub/Guiade-Guias.pdf. Accessed April 22, 2013.
 
41 Schunemann HJ, Woodhead M, Anzueto A, et al. A guide to guidelines for professional societies and other developers of recommendations : Introduction to integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 215-218.
 
42 Shekelle P, Woolf S, Grimshaw J, Schunemann H, Eccles M. Developing clinical practice guidelines : reviewing, reporting, and publishing guidelines ; updating guidelines ; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development. Implementation Science. 2012 ; 7 (1) : 62.
 
43 Yawn BP, Akl EA, Qaseem A, Black P, Campos-Outcalt D. Identifying Target Audiences : Who Are the Guidelines For? : Article 1 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 219-224.
PubMed
44 Guyatt GH, Norris SL, Schulman S, et al. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 ; 141 (2 Suppl) : 53S-70S.
 
45 National Institute for Health and Clinical Excellence. The guidelines manual : Appendix A-Agreements and advice for Guideline Development Group members. 2012 ; http://publications.nice.org.uk/pmg6a. Accessed April 22, 2013.
 
46 National Health and Medical Research Council. Guideline Development and Conflicts of Interest : Identifying and Managing Conflicts of Interest of Prospective Members and Members of NHMRC Committees and Working Groups Developing Guidelines. 2012 ; http://www.nhmrc.gov.au/guidelines-and-publications/information-guideline-developers/guideline-development-and-conflicts. Accessed April 22, 2013.
 
47 Woolf S, Schunemann H, Eccles M, Grimshaw J, Shekelle P. Developing clinical practice guidelines : types of evidence and outcomes ; values and economics, synthesis, grading, and presentation and deriving recommendations. Implementation Science. 2012 ; 7 (1) : 61.
 
48 Kelson M, Akl EA, Bastian H, et al. Integrating Values and Consumer Involvement in Guidelines with the Patient at the Center : Article 8 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 262-268.
 
49 Schunemann H, Fretheim A, Oxman A. Improving the use of research evidence in guideline development : 10. Integrating values and consumer involvement. Health Research Policy and Systems. 2006 ; 4 (1) : 22.
 
50 Boyd E, Bero L. Improving the use of research evidence in guideline development : 4. Managing conflicts of interests. Health Research Policy and Systems. 2006 ; 4 (1) : 16.
PubMed
51 Cancer Care Ontario. Program in Evidence-Based Care Conflict of Interest Policy. 2011 ; http://www.cancercare.on.ca/cms/one.aspx?objectId=7582&contextId=1377. Accessed April 22, 2013.
 
52 Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development : 14. Reporting guidelines. Health Research Policy and Systems. 2006 ; 4 (1) : 26.
 
53 Schunemann H, Oxman A, Fretheim A. Improving the use of research evidence in guideline development : 6. Determining which outcomes are important. Health Research Policy and Systems. 2006 ; 4 (1) : 18.
 
54 Fabbri LM, Boyd C, Boschetto P, et al. How to Integrate Multiple Comorbidities in Guideline Development : Article 10 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 274-281.
PubMed
55 National Institute for Health and Clinical Excellence. Positively Equal : A guide to addressing equality issues in developing clinical guidelines. 2012 ; http://www.nice.org.uk/Media/Default/About/what-wedo/NICE-guidance/NICE-guidelines/Clinical-guidelines/Positively-Equal.pdf. Accessed July 5, 2013.
 
56 Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development : 7. Deciding what evidence to include. Health Research Policy and Systems. 2006 ; 4 (1) : 19.
 
57 Hofmann B. Toward a procedure for integrating moral issues in health technology assessment. Int J Technol Assess Health Care. Summer 2005 ; 21 (3) : 312-318.
 
58 Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development : 8. Synthesis and presentation of evidence. Health Research Policy and Systems. 2006 ; 4 (1) : 20.
 
59 Guyatt G, Akl EA, Oxman A, et al. Synthesis, Grading, and Presentation of Evidence in Guidelines : Article 7 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 256-261.
PubMed
60 Edejer T. Improving the use of research evidence in guideline development : 11. Incorporating considerations of cost-effectiveness, affordability and resource implications. Health Research Policy and Systems. 2006 ; 4 (1) : 23.
 
61 Schunemann H, Fretheim A, Oxman A. Improving the use of research evidence in guideline development : 13. Applicability, transferability and adaptation. Health Research Policy and Systems. 2006 ; 4 (1) : 25.
 
62 Hill SR, Olson LG, Falck-Ytter Y, et al. Incorporating Considerations of Cost-Effectiveness, Affordability, and Resource Implications in Guideline Development : Article 6 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 251-255.
PubMed
63 Schunemann H, Fretheim A, Oxman A. Improving the use of research evidence in guideline development : 9. Grading evidence and recommendations. Health Research Policy and Systems. 2006 ; 4 (1) : 21.
 
64 Wilson KC, Irwin RS, File TM, Schunemann HJ, Guyatt GH, Rabe KF. Reporting and Publishing Guidelines : Article 12 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 293-297.
PubMed
65 Schunemann HJ, Oxman AD, Akl EA, et al. Moving from Evidence to Developing Recommendations in Guidelines : Article 11 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 282-292.
PubMed
66 Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development : 16. Evaluation. Health Research Policy and Systems. 2006 ; 4 (1) : 28.
 
67 Fretheim A, Schunemann H, Oxman A. Improving the use of research evidence in guideline development : 15. Disseminating and implementing guidelines. Health Research Policy and Systems. 2006 ; 4 (1) : 27.
 
68 Grimshaw JM, Schunemann HJ, Burgers J, et al. Disseminating and Implementing Guidelines : Article 13 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 298-303.
PubMed
69 Cancer Care Ontario. Program in Evidence-Based Care Document Assessment and Review Protocol. 2012 ; http://www.cancercare.on.ca/about/programs/pebc/document_review/. Accessed April 22, 2013
 
P.411 掲載の参考文献
1. National Institute for Health and Clinical Excellence. The guidelines manual : Appendix L-Abbreviations and Glossary. 2012 ; http://publications.nice.org.uk/the-guidelines-manual-appendix-l-abbreviations-and-glossary-pmg6d/l2-glossary. Accessed July 21, 2013.
 
2. World Health Organization. Estonian Handbook for Guidelines Development. 2011 ; http://whqlibdoc.who.int/publications/2011/9789241502429_eng.pdf. Accessed April 22, 2013.
 
3. Kunz R, Fretheim A, Cluzeau F, et al. Guideline Group Composition and Group Processes : Article 3 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 229-233.
 
4. Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust. 2011 ; http://www.nap.edu/openbook.php?record_id=13058. Accessed April 22, 2013.
 
5. Kelson M, Akl EA, Bastian H, et al. Integrating Values and Consumer Involvement in Guidelines with the Patient at the Center : Article 8 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 262-268.
 
6. National Institute for Health and Clinical Excellence. Glossary. 2013 ; http://www.nice.org.uk/website/glossary/glossary.jsp. Accessed July 21, 2013.
 
7. National Health and Medical Research Council. Procedures and requirements for meeting the 2011 NHMRC standard for clinical practice guidelines. 2011 ; http://www.nhmrc.gov.au/guidelines/publications/cp133-and-cp133a. Accessed April 22, 2013.
 
8. Yawn BP, Akl EA, Qaseem A, Black P, Campos-Outcalt D. Identifying Target Audiences : Who Are the Guidelines For? : Article 1 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 219-224.
PubMed
9. Atkins D, Perez-Padilla R, MacNee W, Buist AS, Cruz AA. Priority Setting in Guideline Development : Article 2 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 225-228.
PubMed
10. World Health Organization. Health Systems Strengthening Glossary. 2013 ; http://www.who.int/healthsystems/hss_glossary/en/index.html. Accessed July 26, 2013.
 
11. Grimshaw JM, Schunemann HJ, Burgers J, et al. Disseminating and Implementing Guidelines : Article 13 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 298-303.
PubMed
12. The ADAPTE Collaboration. The ADAPTE Process : Resource Toolkit for Guideline Adaptation. Version 2.0. 2009 ; http://www.g-in.net/document-store/working-groups-documents/adaptation/adapte-resource-toolkit-guideline-adaptation-2-0.pdf. Accessed July 5, 2013.
 
13. Schunemann HJ, Osborne M, Moss J, et al. An official American Thoracic Society Policy statement : managing conflict of interest in professional societies. Am J Respir Crit Care Med. Sep 15 2009 ; 180 (6) : 564-580.
 
14. Boyd EA, Akl EA, Baumann M, et al. Guideline Funding and Conflicts of Interest : Article 4 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 234-242.
PubMed
15. Oxman A, Schunemann H, Fretheim A. Improving the use of research evidence in guideline development : 12. Incorporating considerations of equity. Health Research Policy and Systems. 2006 ; 4 (1) : 24.
 
16. AGREE Research Trust. The AGREE Enterprise Website. 2013 ; http://www.agreetrust.org. Accessed July 21, 2013.
 
17. Qaseem A, Forland F, Macbeth F, Ollenschlager G, Phillips S, van der Wees P. Guidelines International Network : Toward international standards for clinical practice guidelines. Ann Intern Med. 2012 ; 156 (7) : 525-531.
PubMed
18. Wilt TJ, Guyatt G, Kunz R, et al. Deciding What Type of Evidence and Outcomes to Include in Guidelines : Article 5 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 243-250.
PubMed
19. Fabbri LM, Boyd C, Boschetto P, et al. How to Integrate Multiple Comorbidities in Guideline Development : Article 10 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 274-281.
PubMed
20. Guyatt G DP, Montori V, Schunemann HJ, Bhandari M,. Putting the patient first : In our practice, and in our use of language. ACP journal club. Jan-Feb 2004 ; 140 (A11).
 
21. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines : 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. Apr 2011 ; 64 (4) : 395-400.
PubMed
22. Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines : 3. Rating the quality of evidence. J Clin Epidemiol. Apr 2011 ; 64 (4) : 401-406.
PubMed
23. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines : 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. Apr 2011 ; 64 (4) : 383-394.
PubMed
24. Schunemann HJ, Oxman AD, Akl EA, et al. Moving from Evidence to Developing Recommendations in Guidelines : Article 11 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proceedings of the American Thoracic Society. 2012 ; 9 (5) : 282-292.
PubMed
25. Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines : 14. Going from evidence to recommendations : the significance and presentation of recommendations. Journal of clinical epidemiology. 2013 ; 66 (7) : 719-725.
PubMed
26. Brown P BK, Chalkidou K, Chalmers I, Clarke M, Fenton M, et al. How to formulate research recommendations. BMJ. Oct 14 2006 ; 333 (7572) : 804-806.
 
27. The GRADE working group. GRADE Working Group. 2013 ; http://www.gradeworkinggroup.org. Accessed July 21, 2013.
 
28. U.S. Preventive Services Task Force. Methods and Processes. 2013 ; http://www.uspreventiveservicestaskforce.org/methods.htm. Accessed July 21, 2013.
 

文献

P.415 掲載の参考文献
1 Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC : The National Academies Press ; 2011.
PubMed
1 相原守夫 [内容の一部訳]. IOMの2つの新基準 :『信頼できる診療ガイドライン』と『医療における解決策の模索 : システマティックレビューのための基準』. 信頼できる診療ガイドライン. 臨床評価. 2013 ; 41 : 253-260.
 
2 The AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines : the AGREE project. Qual Saf Health Care. 2003 ; 12 : 18-23.
PubMed
3 Institute of Medicine. Finding what works in health care standards for systematic reviews. Washington, DC : The National Academies Press ; 2011.
 
3 相原守夫 [内容の一部訳]. IOMの2つの新基準 :『信頼できる診療ガイドライン』と『医療における解決策の模索 : システマティックレビューのための基準』. 医療における解決策の模索 システマティックレビューのための基準. 臨床評価. 2013 ; 41 : 261-264.
 
4 GRADE Working Group (http://www.gradeworkinggroup.org/
 
5 Schunemann HJ, Wiercioch W, Etxeandia I, et al. Guidelines 2.0 : systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ. 2014 ; 186 : E123-E142.
 
6 World Health Organization. WHO Handbook for Guideline Development. 2nd ed. 2014. (http://www.who.int/publications/guidelines/handbook_2nd_ed.pdf)
 
7 Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, edited by Higgins J. and Green S. 2011. (www.cochrane-handbook.org)
 
8 National Institute for Health and Clinical Excellence. Developing NICE guidelines : the manual. 2015. (https://www.nice.org.uk/process/pmg20/chapter/introduction-and-overview)
 
9 公益財団法人日本医療機能評価機構, 医療情報サービス (Medical Information Network Distribution Service : Minds) ガイドラインライブラリ. (https://minds.jcqhc.or.jp/)
 
10 Qaseem A, Forland F, Macbeth F, et al. Guidelines International Network : Toward international standards for clinical practice guidelines. Ann Intern Med. 2012 ; 156 : 525-531.
PubMed
11 GIN-McMaster Guideline Development Checklist. (https://cebgrade.mcmaster.ca/guidecheck.html)
 
12 Guyatt GH, Norris SL, Schulman S, et al. American College of Chest Physicians. Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012, 141 (2 Suppl) : 53S-70S.
 
13 一般社団法人日本蘇生協議会. JRC蘇生ガイドライン 2015. 東京 : 医学書院 ; 2015.
 
14 3学会合同ARDS診療ガイドライン 2016作成委員会. ARDS診療ガイドライン 2016-GRADEシステムを用いたシステマティックレビューと推奨-. 東京 : 総合医学社 ; 2016.
 
15 Oxman AD, Fretheim A, Schunemann HJ. Improving the use of research evidence in guideline development : introduction. Health Res Policy Syst. 2006 ; 4 : 12.
PubMed
16 Schunemann HJ, Woodhead M, Anzueto A, et al. A guide to guidelines for professional societies and other developers of recommendations : introduction to integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012 ; 9 : 215-218.
 
17 World Health Organization. Estonian Handbook for Guidelines Development. 2011 (http://whqlibdoc.who.int/publications/2011/9789241502429_eng.pdf.).
 
18 Saudi Arabian Handbook for Healthcare Guideline Development, 2013. (https://www.moh.gov.sa/endepts/Proofs/Documents/Saudi%20Arabian%20Handbook%20for%20Healthcare%20Guideline%20Development-updated%2013-11-2014.pdf. Accessed on 11 September 2017)
 
19 Brouwers MC, Kho ME, Browman GP, et al. AGREE II : Advancing guideline development, reporting and evaluation in health care. CMAJ. 2010 ; 182 : E839-E842.
PubMed
20 Reporting Items for Practice Guidelines in Healthcare (RIGHT). (http://www.right-statement.org/. Accessed on 1st March 2018)
 
21 NICE patient and public involvement policy. London : National Institute for Health and Care Excellence ; 2014. (http://www.nice.org.uk/about/nice-communities/public-involvement/patient-and-public-involvement-policy, Accessed 11 September 2017)
 
22 Institute of Medicine. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC : The National Academies Press ; 2008. (https://www.nap.edu/download/12598, Accessed on 11 September 2017)
 
23 Schunemann HJ, Osborne M, Moss J, et al. An official American Thoracic Society policy statement : Managing conflict of interest in professional societies. Am J Respir Crit Care Med. 2009 ; 180 : 564-580.
PubMed
24 G-I-N Policy for Disclosure of Interests and Management of Conflicts. (http://www.g-i-n.net/document-store/policies-and-articles-of-association/coi-policy-oct-2015, Accessed on 11 September 2017)
 
25 Schunemann HJ, Al-Ansary LA, Forland F, et al. Guidelines International Network : Principles for Disclosure of Interests and Management of Conflicts in Guidelines. Ann Intern Med. 2015 ; 163 : 548-553.
PubMed
26 相原守夫. 診療ガイドラインのためのGRADEシステム, 第2版. 弘前 : 凸版メディア ; 2015.
 
27 WHO. Guidelines for WHO guidelines. Geneva : WHO ; 2003. (http://whqlibdoc.who.int/hq/2003/EIP_GPE_EQC_2003_1.pdf. Accessed on 21 May 2012)
 
28 Guyatt GH, Oxman AD, Vist G, et al. Rating quality of evidence and strength of recommendations GRADE : an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008 ; 336 : 924-926.
PubMed
29 Guyatt GH, Oxman AD, Kunz R, et al. What is "quality of evidence" and why is it important to clinicians? BMJ. 2008 ; 336 : 995-998.
PubMed
30 Schunemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008 ; 336 : 1106-1110.
PubMed
31 Guyatt GH, Oxman AD, Kunz R, et al. Incorporating considerations of resources use into grading recommendations. BMJ. 2008 ; 336 : 1170.
PubMed
32 Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. BMJ. 2008 ; 336 : 1049-1051.
PubMed
33 Jaeschke R, Guyatt GH, Dellinger P, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ. 2008 ; 337 : a744.
PubMed
34 Brozek JL, Alonso-Coello P, Lang D, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009 ; 64 : 669-6677.
PubMed
35 Brozek JL, Elie Akl, Jaeschke R, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy. 2009 ; 64 : 1109-1116.
 
36 Brozek JL, Elie Akl, Compalati E, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 3 of 3. The GRADE approach to developing recommendations. Allergy. 2011 ; 66 : 589-595.
 
37 Guyatt GH, Oxman AD, Schunemann HJ, et al. GRADE guidelines : a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011 ; 64 : 380-382.
PubMed
38 Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines : 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011 ; 64 : 383-394.
PubMed
39 Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines : 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011 ; 64 : 395-400.
PubMed
40 Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines : 3. Rating the quality of evidence. J Clin Epidemiol. 2011 ; 64 : 401-406.
PubMed
41 Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines : 4. Rating the quality of evidence-study lim itations (risk of bias). J Clin Epidemiol. 2011 ; 64 : 407-415.
 
42 Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines : 5. Rating the quality of evidence-publication bias. J Clin Epidemiol. 2011 ; 64 : 1277-1282.
PubMed
43 Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence-imprecision J Clin Epidemiol. 2011 ; 64 : 1283-1293.
PubMed
44 Guyatt GH, Oxman AD, Kunz R, et al. GRADE Working Group. GRADE guidelines : 7. Rating the quality of evidence-inconsistency. J Clin Epidemiol. 2011 ; 64 : 1294-1302.
 
45 Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines : 8. Rating the quality of evidence-indirectness. J Clin Epidemiol. 2011 ; 64 : 1303-1310.
PubMed
46 Guyatt GH, Oxman AD, Sultan S, et al. GRADE guidelines : 9. Rating up the quality of evidence. J Clin Epidemiol. 2011 ; 64 : 1311-1316.
PubMed
47 Brunetti M, Shemilt I, Pregno S, et al. GRADE guidelines : 10. Considering resource use and rating the quality of economic evidence. J Clin Epidemiol. 2013 ; 66 : 140-150.
PubMed
48 Guyatt G, Oxman AD, Sultan S, et al. GRADE guidelines : 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol. 2013 ; 66 : 151-157.
PubMed
49 Guyatt GH, Oxman AD, Santesso N, et al. GRADE guidelines : 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol. 2013 ; 66 : 158-172.
PubMed
50 Guyatt GH, Thorlund K, Oxman AD, et al. GRADE guidelines : 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol. 2013 ; 66 : 173-183.
PubMed
51 Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines : 14. Going from evidence to recommendations : the significance and presentation of recommendations. J Clin Epidemiol. 2013 ; 66 : 719-725.
PubMed
52 Andrews JC, Schunemann HJ, Oxman AD, et al. GRADE guidelines : 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol. 2013 ; 66 : 726-735.
PubMed
53 Shunemann HJ, Mustaga R, Brozek J, et al. GRADE Guidelines : 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. J Clin Epidemiol. 2016 ; 76 : 89-98.
 
54 Guyatt GH, Ebrahim S, Alonso-Coello P, et al. GRADE guidelines 17 : assessing the risk of bias associated with missing participant outcome data in a body of evidence. J Clin Epidemiol. 2017 ; 87 : 14-22.
 
55 Schunemann HJ, Cuello C, Akl EA, et al. GRADE Guidelines : 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence, J Clin Epidemiol. 2018 Feb 9. pii : S0895-4356 (17) 31031-4., doi : 10.1016/j.jclinepi. 2018. 01. 012.
 
56 Zhang Y, Alonso-Coello P, Guyatt G, et al. GRADE Guidelines : 19. Assessing the certainty of evidence describing the relative importance of outcomes or values and preferences-Risk of bias and indirectness, J Clin Epidemiol. 2018. doi : 10.1016/j.jclinepi. 2018. 01. 013.
 
57 小島原典子, 中山健夫, 森實敏夫, 他. Minds診療ガイドライン作成マニュアル 2017. (Available from https://minds.jcqhc.or.jp/s/guidance_2017)
 
58 Schunemann H, Brozek J, Guyatt G, et al, eds. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, 2013. (Available from www.guidelinedevelopment.org/handbook)
 
59 http://www.chestnet.org/Guidelines-and-Resources/Guidelines-and-Consensus-Statements/Methodology (Accessed on 11 September 2017).
 
60 http://www.uptodate.com/home/grading-tutorial (Accessed on 11 September 2017).
 
61 Akl EA, Briel M, You JJ, et al. LOST to follow-up Information in Trials (LOST-IT) : a protocol on the potential impact. Trials. 2009 ; 10 : 40.
PubMed
62 Williamson PR, Altman DG, Bagley H, et al. The COMET Handbook : version 1.0. Trials. 2017 ; 18 (Suppl 3) : 280.
 
63 Shunemann HJ, Wiercioch W, Brozek J, et al. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations : GRADE-ADOLOPMENT. J Clin Epidemiol. 2017 ; 81 : 101-110.
 
64 Hazlewood GS, Akhavan P, Schieir O, et al. Adding a "GRADE" to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II J Clin Epidemiol. 2014 ; 67 : 1274-1285.
 
65 Shea BJ, Hamel C, Wells GA, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiology. 2009 ; 62 : 1013-1020.
 
66 https://www.ncbi.nlm.nih.gov/pubmed/
 
67 http://www.cochranelibrary.com/
 
68 http://jp.elsevier.com/online-tools/embase
 
69 http://www.jamas.or.jp/
 
70 https://rayyan.qcri.org/welcome
 
71 http://community.cochrane.org/tools/review-production-tools/covidence (Accessed on 12 September 2017)
 
72 http://community.cochrane.org/tools/review-production-tools/revman-5 (Accessed on 12 September 2017)
 
73 http://www.prisma-statement.org/ (Accessed on 1 March 2018)
 
74 Schunemann HJ, Cook D, Guyatt G. Methodology for antithrombotic and thrombolytic therapy guideline development : American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th Edition). Chest. 2008 ; 133 : 113S-122S.
PubMed
75 Murad MH, Altayar O, Bennett M, et al. Using GRADE for evaluating the quality of evidence in hyperbaric oxygen therapy clarifies evidence limitations. J Clin Epidemiol. 2014 ; 67 : 65-72.
PubMed
76 Kim SY, Park JE, Lee YJ, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013 ; 66 : 408-414.
PubMed
77 Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I : a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016 ; 355 : i4919
 
78 PreGRADE excersice. docx (http://pregnancy.cochrane.org/sites/pregnancy.cochrane.org/files/public/uploads/PreGrade%20exercise.docx Accessed on 18 September 2017)
 
79 Furukawa TA, Cipriani A, Atkinson LZ, et al. Placebo response rates in antidepressant trials : a systematic review of published and unpublished double-blind randomised controlled studies. Lancet Psychiatry. 2016 ; 3 : 1059-1066.
PubMed
80 Furukawa TA, Miura T, Chaimani A, et al. Using the contribution matrix to evaluate complex study limitations in a network metaanalysis : a case study of bipolar maintenance pharmacotherapy review. BMC Res Notes. 2016 ; 9 : 218.
 
81 http://methods.cochrane.org/adverseeffects/
 
82 Chou R, Fu R, Carson S, et al. Methodological shortcomings predicted lower harm estimates in one of two sets of studies of clinical interventions. J Clin Epidemiol. 2007 ; 60 : 18-28.
PubMed
83 Viswanathan M, Ansari MT, Berkman ND, et al. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions. Agency for Healthcare Research and Quality Methods Guide for Comparative Effectiveness Reviews. March 2012. AHRQ Publication No. 12-EHC047-EF (Available at : www.effectivehealthcare.ahrq.gov/).
 
84 Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009 ; 172 : 137-159.
PubMed
85 Borenstein M, Hedges LV, Higgins JPT, et al. Introduction to Meta-Analysis. Chichester, UK : Wiley ; 2009.
 
86 Hultcrantz M, Rind D, Akl EA, et al. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiolgy. 2017 ; 87 : 4-13.
 
87 Schunemann HJ. Interpreting GRADE's levels of certainty or quality of the evidence : GRADE for statisticians, considering review information size or less emphasis on imprecision? J Clin Epidemiolgy. 2016 ; 75 : 6-15
PubMed
88 Peters JL, Sutton AJ, Jones DR, et al. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008 ; 61 : 991-996.
PubMed
89 Palmer TM, Peters JL, Sutton AJ, et al. Contour-enhanced funnel plots for meta-analysis. Stata J. 2008 ; 8 : 242-254.
 
90 Schunemann H, Hill S, Guyatt G, et al. The GRADE approach and Bradford Hill's criteria for causation. J Epidemiol Community Health. 2011 ; 65 : 392-395.
 
91 GRADEpro GDT : GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). (Available from gradepro.org)
 
92 Carrasco-Labra A, Brignardello-Petersen R, Santesso N, et al. Improving GRADE evidence tables. part 1 : a randomized trial shows improved understanding of content in summary of findings tables with a new format. J Clin Epidemiol. 2016 ; 74 : 7-18.
PubMed
93 Langendam M, Carrasco-Labra A, Santesso N, et al. Improving GRADE evidence tables. part 2 : a systematic survey of explanatory notes shows more guidance is needed. J Clin Epidemiol. 2016 ; 74 : 19-27.
 
94 Santesso N, Carrasco-Labra A, Langendam M, et al. Improving GRADE evidence tables. part 3 : detailed guidance for explanatory footnotes supports creating and understanding GRADE certainty in the evidence judgments. J Clin Epidemiol. 2016 ; 74 : 28-30.
PubMed
95 Guyatt GH, Schunemann HJ, Djulbegovic B, et al. Guideline panels should not GRADE good practice statements. J Clinical Epidemiol. 2015 ; 68 : 597-600.
 
96 Smith GC. Parachute use to prevent death and major trauma related to gravitational challenge : systematic review of randomised controlled trials. Int J Prosthodont. 2006 ; 19 : 126-128.
 
97 Brito JP, Domecq JP, Murad MH, et al. The Endocrine Society guidelines : when the confidence cart goes before the evidence horse. J Clin Endocrinol Metab. 2013 ; 98 : 3246-3252.
 
98 Alexander PE, Bero L, Montori VM, et al. World Health Organization recommendations are often strong based on low confidence in effect estimates. J Clin Epidemiol. 2014 ; 67 : 629-634.
PubMed
99 Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016. Intensive Care Med. 2017 ; 43 : 304-377.
PubMed
100 Neumann I, Akl EA, Vandvik OA, et al. Chapter 28.1 Assessing the strength of recommendations : The GRADE approach. In : Guyatt G, Rennie D, Meade MO, Cook DJ, eds. Users' guides to the medical literature-a manual for evidence-based clinical practice. 3rd ed. JAMAevidence. 2015. p.561-573.
 
101 MacLean S, Mulla S, Akl EA, et al. Patient Values and Preferences in Decision Making for Antithrombotic Therapy A Systematic Review. Chest. 2012 ; 141 (2 Suppl) : e1S-e23S.
 
102 Zhang Y, Coello PA, Brozek J, et al. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach. Health Qual Life Outcomes. 2017 ; 15 : 52.
PubMed
103 Yepes-Nunez JJ, Zhang Y, Xie F, et al. Forty-two systematic reviews generated 23 items for assessing the risk of bias in values and preferences' studies. J Clin Epidemiol. 2017 ; 85 : 21-31.
PubMed
104 Berger ML, Bingefors K, Hdblom EC, et al, eds. Health Care Cost, Quality, and Outcomes-ISPOR Book of Terms. USA : International Society for Pharmacoecomics and Outcomes Research ; 2003. (鎌江伊三夫, 監訳. ヘルスケアサイエンスのための医薬経済学用語集. 東京 : 医薬出版センター ; 2011)
 
105 Systematic review of economic evaluations of budesonide for maintenance of remission in Crohn's disease. (https://www.nice.org.uk/process/pmg15/chapter/appendix-d-grade-profile-and-economic-evidence-profile Accessed on 14 September 2017)
 
106 http://www.decide-collaboration.eu/
 
107 Treweek S, Oxman AD, Alderson P, et al. DECIDE Consortium. Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE) : protocol and preliminary results. Implement Sci. 2013 ; 8 : 6.
PubMed
107 相原守夫, 訳. エビデンスに裏付けられた情報に基づく決断と診療を支援するコミュニケーション戦略の策定と評価 (DECIDE) : プロトコルと予備的結果. 臨床評価. 2013 ; 41 : 431-464
 
108 Murphy MK, Black NA, Lamping DL, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess. 1998 ; 2 : i-iv, 1-88.
 
109 Fitch K, Bernstein AJ, Aguilar MS, et al. The RAND/UCLA Appropriateness Method User's Manual, 2001. (http://www.rand.org/content/dam/rand/pubs/monograph_reports/2011/MR1269.pdf Accessed on 14 September 2017)
 
110 一般社団法人日本リウマチ学会. 関節リウマチ診療ガイドライン. 大阪 : メディカルレビュー社 ; 2014.
 
111 http://www.agreetrust.org/agree-ii/
PubMed
112 Shiffman RN, Shekelle P, Overhage JM, et al. Standardized reporting of clinical practice guidelines : a proposal from the Conference on Guideline Standardization. Ann Intern Med. 2003 ; 139 : 493-498.
PubMed
113 Shaneyfelt TM, Mayo-Smith MF and Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA. 1999 ; 281 : 1900-1905.
PubMed
114 Schunemann HJ, Wiercioch W, Etxeandia I, et al. Guidelines 2.0 : systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ. 2014 ; 186 : E123-E142.
 
115 http://www.gradeworkinggroup.org/docs/Criteria_for_using_GRADE_2016-04-05.pdf
 
116 Vandvik PO, Brandt L, Alonso-Coello P, et al. Creating clinical practice guidelines we can trust, use, and share : a new era is imminent. Chest. 2013 ; 144 : 381-389.
 
117 Kristiansen A, Brandt L, Agoritsas T, et al. Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines : results from the Norwegian adaptation of the Antithrombotic Therapy and the Prevention of Thrombosis, 9th Ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2014 ; 146 : 735-761.
PubMed
118 https://www.magicapp.org/
PubMed
119 Baumann MH, Lewis SZ, Gutterman D. ACCP Evidence-Based Guideline Development : A Successful and Transparent Approach Addressing Conflict of Interest, Funding, and Patient-Centered Recommendations. Chest. 2007 ; 132 : 1015-1024.
PubMed
120 Djulbegovic B. A Framework to Bridge the Gaps Between Evidence-Based Medicine, Health Outcomes, and Improvement and Implementation Science. J Oncol Pract. 2014 ; 10 : 200-202.
PubMed
121 Schunemann HJ, Oxman AD, Akl EA, et al. Moving from Evidence to Developing Recommendations in Guidelines Article 11 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proc Am Thorac Soc. 2012 ; 9 : 282-292.
PubMed
122 Wilson KC, Schunemann HJ. An Appraisal of the Evidence Underlying Performance Measures for Community-Acquired Pneumonia. Am J Respir Crit Care Med. 2011 ; 183 : 1454-1462.
PubMed
123 Kahn JM, Gould MK, Krishnan JA, et al. An Official American Thoracic Society Workshop Report : Developing Performance Measures from Clinical Practice Guidelines. Ann Am Thorac Soc. 2014 ; 11 : S186-S195.
PubMed
124 Garner P, Hopewell S, Chandler J, et al. When and how to update systematic reviews : consensus and checklist. BMJ. 2016 ; 354 : i3507.
PubMed
125 http://www.bmj.com/rapid-recommendations
 
126 Akl EA, Johnston BC, Alonso-Coello P, et al. Addressing dichotomous data for participants excluded from trial analysis : a guide for systematic reviewers. PLoS One. 2013 ; 8 : e57132.
 
127 Ebrahim S, Akl EA, Mustafa RA, et al. Addressing continuous data for participants excluded from trial analysis : a guide for systematic reviewers. J Clin Epidemiol. 2013 ; 66 : 1014-1021.
PubMed
128 Ebrahim S, Johnston BC, Akl EA, et al. Addressing continuous data measured with different instruments for participants excluded from trial analysis : a guide for systematic reviewers. J Clin Epidemiol. 2014 ; 67 : 560-570.
PubMed
129 Darzi A, Harfouche M, Arayssi T, et al. Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region : an exemplar of the GRADE Adolopment. Health Qual Life Outcomes. 2017 ; 15 : 183
PubMed
130 Alonso-Coello P, Schunemann HJ, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks : a systematic and transparent approach to making well informed healthcare choices. 1 : Introduction. BMJ. 2016 ; 353 : i2016
PubMed
131 Alonso-Coello P, Oxman AD, Moberg J. et al. GRADE evidence to decision frameworks : 2. Clinical practice guidelines. BMJ. 2016 ; 353 : i2089
PubMed
132 Selva A, Sanabria AJ, Pequeno S, et al. Incorporating patients' views in guideline development : a systematic review of guidance documents. J Clin Epidemiol. 2017 ; 88 : 102-112.
PubMed
133 Zhang Y, Alonso-Coello P, Yepes-Nunez JJ, et al. GRADE guidance for rating the certainty of a body of evidence describing the relative importance of outcomes or values and preferences. Abstracts of the Global Evidence Summit, Cape Town, South Africa. Cochrane Database of Systematic Reviews 2017, Issue 9 (Suppl 2). https://www.globalevidencesummit.org/abstracts/grade-guidance-rating-certainty-body-evidence-describing-relative-importance-outcomes-or
 
134 Yu T, Fain K, Boyd CM, et al. Benefits and harms of roflumilast in moderate to severe COPD. Thorax. 2014 ; 69 : 616-622.
PubMed
135 Welch VA, Akl EA, Guyatt G, et al. GRADE equity guidelines 1 : health equity in guideline developmentdintroduction and rationale. J Clin Epidemiol. 2017 ; 90 : 59-67.
PubMed
136 Akl EA, Welch V, Pottie K, et al. GRADE Equity Guidelines 2 : Considering health equity in GRADE guideline development : Equity extension of the Guideline Development Checklist. J Clin Epidemiol. 2017 ; 90 : 68-75.
PubMed
137 Welch VA, Akl EA, Pottie K, et al. GRADE equity guidelines 3 : health equity considerations in rating the certainty of synthesized evidence. J Clin Epidemiol. 2017 ; 90 : 76-83.
PubMed
138 Pottie K, Welch V, Morton R, et al. GRADE equity guidelines 4 : guidance on how to assess and address health equity within the evidence to decision process. J Clin Epidemiol. 2017 ; 90 : 84-91.
PubMed
139 Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007 ; 8 : 16.
PubMed
140 Skoetz N, Meerpohl J, Weigl A, et al. Presentation of time-to-event outcomes in GRADE Summary of Finding (SOF) tables : Evaluation of Cochrane Cancer Reviews. Abstracts of the Global Evidence Summit, Cape Town, South Africa. Cochrane Database of Systematic Reviews 2017, Issue 9 (Suppl 2).
 
141 Guyatt GH, Alonso-Coello P, Schunemann HJ, et al. Guideline panels should seldom make good practice statements : guidance from the GRADE Working Group. J Clin Epidemiol. 2016 ; 80 : 3-7.
 
142 Watine J. Are not good practice statements necessarily based on evidence? Are their grades always strong? J Clin Epidemiol. 2016 ; 70 : 283-284.
 
143 Whiting P, Savovic J, Higgins JPT, et al. ROBIS : A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016 ; 69 : 225-234.
PubMed
144 Shekelle PG, Ortiz E, Rhodes S, et al. More informative abstracts of articles describing clinical practice guidelines : how quickly for guidelines become outdated? JAMA. 2001 ; 286 : 1461-1467.
 
145 Vandvik PO, Santesso N, Akl EA, et al. Formatting modifications in GRADE evidence profiles improved guideline panelists comprehension and accessibility to information. A randomized trial. J Clin Epidemiol. 2012 ; 65 : 748-755.
 
146 Wetterslev J, Thorlund K, Brok J, et al. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008 ; 61 : 64-75.
PubMed
147 Miladinovic B, Hozo I, Djulbegovic B. Trial sequential boundaries for cumulative meta-analyses. Stata Journal. 2013 ; 13 : 577-591.
 
148 Hemingway H, Croft P, Perel P, et al, for the PROGRESS Group. Prognosis research strategy (PROGRESS) 1 : A framework for researching clinical outcomes. BMJ. 2013 ; 346 : e5595.
PubMed
149 Riley RD, Hayden JA, Steyerberg EW, et al, for the PROGRESS Group. Prognosis Research Strategy (PROGRESS) 2 : Prognostic factor research. PLoS Med. 2013 ; 10 : e1001380.
PubMed
150 Steyerberg EW, Moons KG, Van Der Windt DA, et al, for the PROGRESS Group. Prognosis Research Strategy (PROGRESS) 3 : Prognostic model research. PLoS Med. 2013 ; 10 : e1001381.
PubMed
151 Hingorani A, van der Windt D, Riley R, et al ; the PROGRESS Group. Prognosis research strategy (PROGRESS) 4 : Stratified medicine research. BMJ. 2013 ; 345 : e5793.
 
152 Iorio A, Spencer FA, Falavigna M, et al. Use of GRADE for assessment of evidence about prognosis : rating confidence in estimates of event rates in broad categories of patients. BMJ. 2015 ; 350 : h870.
PubMed
153 Spencer FA, Iorio A, You J, et al. Uncertainties in baseline risk estimates and confidence in treatment effects. BMJ. 2012 ; 345 : e7401.
PubMed
154 Don-Wauchope AC, Santaguida PL. Grading Evidence for Laboratory Test Studies Beyond Diagnostic Accuracy : Application to Prognostic Testing. EJIFCC. 2015 ; 26 : 168-182.
PubMed
155 Huguet A, Hayden JA, Stinson J, et al. Judging the quality of evidence in reviews of prognostic factor research : adapting the GRADE framework. Syst Rev. 2013 ; 2 : 71.
PubMed
156 Busse JW, Guyatt GH. Tool to assess risk of bias in case control studies. (http://distillercer.com/wp-content/uploads/2014/02/Tool-to-Assess-Risk-of-Bias-in-Case-Control-Studies-Aug-21_2011.doc)
 
157 Busse JW, Guyatt GH. Tool to assess risk of bias in cohort studies. (http://distillercer.com/wp-content/uploads/2014/02/Tool-to-Assess-Risk-of-Bias-in-Cohort-Studies.doc)
 
158 Randolph AG, Cook DJ, Guyatt G. Prognosis. In : Guyatt G, Rennie D, Meade MO, et al, eds. Users' guides to the medical literature-a manual for evidence-based clinical practice. 3rd ed. JAMAevidence ; 2015. p.421-429.
 
159 http://methods.cochrane.org/prognosis/our-publications
 
160 https://abstracts.cochrane.org/2014-hyderabad/probast-introduction-new-risk-bias-tool-prediction-modelling-studies
 
161 McLellan J, Heneghan CJ, Perera R, et al. B-type natriuretic peptide-guided treatment for heart failure. Cochrane Database Syst Rev. 2016 ; 12 : CD008966.
PubMed
162 http://methods.cochrane.org/prognosis/ Accessed on 18 September 2017.
 
163 Yousef F, Cardwell C, Cantwell MM, et al. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus : a systematic review and meta-analysis. Am J Epidemiol. 2008 ; 168 : 237-249.
PubMed
164 Su Y, Norris JL, Zang C, et al. Incidence of hepatitis C virus infection in patients on hemodialysis : a systematic review and meta-analysis. Hemodial Int. 2013 ; 17 : 532-541.
PubMed
165 Lewin S, Bosch-Capblanch X, Oliver S, et al. Guidance for Evidence-Informed Policies about Health Systems : Assessing How Much Confidence to Place in the Research Evidence. PLoS Med. 2012 ; 9 : e1001187.
PubMed
166 Oxman AD, Lavis JN, Lewin S, et al. SUPPORT Tools for evidence-informed health Policymaking (STP) 1 : What is evidence-informed policymaking? Health Res Policy Syst. 2009 ; 7 Suppl 1 : S1.
 
167 Giacomini M, Cook DJ. Qualitative research. In : Guyatt G, Rennie D, Meade MO, et al, eds. Users' guides to the medical literature-a manual for evidence-based clinical practice. 3rd ed. JAMAevidence ; 2015. p.285-297.
 
168 Goldsmith MR, Bankhead CR, Austoker J. Synthesising quantitative and qualitative research in evidence-based patient information. J Epidemiol Community Health. 2007 ; 61 : 262-270.
PubMed
169 Munn Z, Porritt K, Lockwood C, et al. Establishing confidence in the output of qualitative research synthesis : the ConQual approach. BMC Medical Research Methodology. 2014 ; 14 : 108.
PubMed
170 Tufanaru C, Peters M. Confidence in qualitative synthesised findings : A principled and pragmatic critique of ConQual and GRADE-CERQual. Abstracts of the Global Evidence Summit, Cape Town, South Africa. Cochrane Database of Syst Rev. 2017. Issue 9 (Suppl 2). dx. doi : org/10.1002/14651858. CD201702.
 
171 Schreiber R, Crooks D Stern PN. Qualitative meta-analysis. In Morse JM ed. Completing a qualitative Project. Thousand Oaks, CA : Sage publications ; 1997. p.311-326.
 
172 Sandelowski M, Docherty S, Emden C. Focus on qualitative methods. Qualitative metasynthesis : issues and techniques. Res Nurs Health. 1997 ; 20 : 365-371.
PubMed
173 Creswell JW. Qualitative inquiry & research design : Choosing among five approaches. Thousand Oaks : Sage publications ; 2007.
 
174 Liamputtong P, Ezzy D. Qualitative reseach methods. 2nd ed. Melbourne, Victoria : Oxford University Press ; 2005.
 
175 Lewin S, Glenton C, Noyes J, et al. CerQual approach : assessing how much certainty to place in findings from qualitative evidence syntheses. Quebec, Canada ; 21st Cochrane Colloquium ; 2013.
 
176 Lewin S, Glenton C, Munthe-Kaas H, et al. Using Qualitative Evidence in Decision Making for Health and Social Interventions An Approach to Assess Confidence in Findings from Qualitative Evidence Syntheses (GRADE-CERQual). PLoS Med. 2015 ; 1 : e1001895.
 
177 Glenton C, Lewin S, Gulmezoglu AM. Expanding the evidence base for global recommendations on health systems : strengths and challenges of the OptimizeMNH guidance process. Implement Sci. 2016 ; 11 : 98.
PubMed
178 Noblit GW, Hare RD. Meta-ethnography : Synthesizing qualitative studies. Newbury Park, CA : Sage publications ; 1988. p.26-29.
 
179 Noyes J, Hannes K, Booth A, et al. Chapter 20 : Qualitative research and Cochrane reviews. In : Higgins JPT, Green S, eds, Cochrane Handbook for Systematic Reviews of Interventions Version 5.3.0 (updated October 2015). The Cochrane Collaboration, 2015. (Available from http://qim.cochrane.org/supplemental-handbook-guidance)
 
180 石垣和子, 山本則子. なぜいま質的研究のメタ統合が必要か. 看護研究. 2008 ; 41 : 351-357.
 
181 Britten N, Campbell R, Pope C. et al. Using meta ethnography to synthesise qualitative research : a worked example. J Health Serv Res Policy. 2002 ; 7 : 209-15.
PubMed
182 島田美紀代. 質的研究のメタ統合におけるメタエスノグラフィー. 看護研究. 2008 ; 41 367-371.
 
183 Glenton C, Lewin S. Using evidence from qualitative research in guideline development : approaches and tools. CERQual Workshop Tokyo_1_Using quali evidence in guidelines_2016 09 12. pptx (未公開)
 
184 Glenton C. The GRADE-CERQual approach for assessing how much confidence to place in the findings of qualitative evidence syntheses. CERQual Workshop Tokyo_2_CERQual outline_2016 12 09. pptx (未公開)
 
185 Glenton C. Presenting findings from qualitative evidence syntheses and GRADE-CERQual confidence assessments. CERQual Workshop BCN_3_ SOQF and EtD_revised_2016 03 14. pptx (未公開)
 
186 Glenton C. Presenting findings from qualitative evidence syntheses and GRADE-CERQual confidence assessments. CERQual Workshop BCN_3_ SOQF and EtD_revised_2016 03 14. pptx (未公開)
 
187 Lewin S, Booth A, Glenton C, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings : introduction to the series. Implement Sci. 2018 ; 13 (Suppl 1) : 2.
 
188 Lewin S, Bohren M, Rashidian A, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 2 : how to make an overall CERQual assessment of confidence and create a Summary of Qualitative Findings table. Implement Sci. 2018 ; 13 (Suppl 1) : 10.
 
189 Munthe-Kaas M, Bohren MA, Glenton C, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 3 : how to assess methodological limitations. Implement Sci. 2018 ; 13 (Suppl 1) : 9.
 
190 Colvin CJ, Garside R, Wainwright M, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 4 : how to assess coherence. Implement Sci. 2018 ; 13 (Suppl 1) : 13.
 
191 Glenton C, Carlsen B, Lewin S, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 5 : how to assess adequacy of data. Implement Sci. 2018 ; 13 (Suppl 1) : 14.
 
192 Noyes J, Booth A, Lewin S, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 6 : how to assess relevance of the data. Implement Sci. 2018 ; 13 (Suppl 1) : 4.
 
193 Booth A, Lewin S, Glenton C, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 7 : understanding the potential impacts of dissemination bias. Implement Sci. 2018 ; 13 (Suppl 1) : 12.
 
194 Critical Appraisal Skills Programme (CASP). http://www.casp-uk.net/casp-tools-checklists
 
195 http://caspjp.umin.ac.jp/materials/caspsheets/files/Qual_j.pdf
 
196 Puhan MA, Schunemann HJ, Murad MH, et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2014 ; 349 : g5630.
 
197 Dulai PS, Singh S, Marquez E, et al. Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia : systematic review and network meta-analysis. BMJ. 2016 ; 355 : i6188.
PubMed
198 Rochwerg B, Alhazzani W, Sindi A, et al. Fluid resuscitation in sepsis : a systematic review and network meta-analysis. Ann Intern Med. 2014 ; 161 : 347-355.
PubMed
199 Chaimani A, Higgins JP, Mavridis D, et al. Graphical tools for network meta-analysis in STATA. PLoS One. 2013, 8 : e76654.
 
200 Salanti G, Giovane CD, Chaimani A, et al. Evaluating the Quality of Evidence from a Network Meta-Analysis. PLoS One. 2014 ; 9 : e99682.
 
201 Chaimani A, Salanti G. Visualizing assumptions and results in network meta-analysis : The network graphs package. Stata Journal, 2015 ; 15 : 905-950.
 
202 Furukawa TA, Miura T, Chaimani A, et al. Using the contribution matrix to evaluate complex study limitations in a network metaanalysis : a case study of bipolar maintenance pharmacotherapy review. BMC Res Notes. 2016 ; 9 : 218.
 
203 Biondi-Zoccai G, ed. Network Meta-Analysis : Evidence Synthesis with Mixed Treatment Comparison. New York : Nova Science Publishers ; 2014.
 
204 Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997 ; 50 : 683-691.
PubMed
205 Dias S, Welton NJ, Caldwell DM, et al. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010 ; 29 : 932-944.
PubMed
206 van Valkenhoef G, Lu G, de Brock B. et al. Automating network meta-analysis. Res Synth Methods. 2012 ; 3 : 285-299.
PubMed
207 Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010 ; 36 : 1-48.
 
208 Brown S, Hutton B, Clifford T, et al. A Microsoft-Excel-based tool for running and critically appraising network meta-analyses-an overview and application of NetMetaXL. Syst Rev. 2014 ; 3 : 110.
PubMed
209 森實敏夫. ネットワークメタアナリシス. あいみっく. 2015 ; 36 : 31-39.
 
210 Brignardello-Petersen R, Bonner A, Alexander PE, et al. Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis, J Clin Epidemiol. 2018 ; 93 : 36-44.
 
211 A Network Meta-Analysis Toolkit. (http://methods.cochrane.org/cmi/network-meta-analysis-toolkit [accessed 1 March 2018])
 
212 Katsanos AH, Mavridis D, Parissis J. et al. Novel oral anticoagulants for the secondary prevention of cerebral ischemia : a network meta-analysis. Ther Adv Neurol Disord. 2016 ; 9 : 359-368.
PubMed
213 http://training.cochrane.org/resource/confidence-network-meta-analysis-nma-study-limitations
 
214 Chaimani A, Papakonstantinou T, Nikolakopoulou A, et al. CINeMA : a web application to evaluate the Confidence In Network Meta-Analysis results. Abstracts of the Global Evidence Summit, Cape Town, South Africa. Cochrane Database of Systematic Reviews 2017, Issue 9 (Suppl 2). (https://www.globalevidencesummit.org/abstracts/cinema-web-application-evaluate-confidence-network-meta-analysis-results)
 
215 Schunemann HJ, Mustafa RA. Decision-making about healthcare related tests and diagnostic strategies Series . Paper 1 : a new series on testing to improve people's health. J Clin Epidemiol. 2017 ; 92 : 16-17.
 
216 Mustafa RA, Wiercioch W, Cheung A, et al. Decision-making about healthcare related tests and diagnostic strategies : Paper 2 : a review of methodological and practical challenges. J Clin Epidemiol. 2017 ; 92 : 18-28.
PubMed
217 Mustafa RA, Wiercioch W, Falavigna M, et al. Decision-making about healthcare related tests and diagnostic strategies : Paper 3 : a systematic review shows limitations in most tools designed to assess quality and develop recommendations. J Clin Epidemiol. 2017 ; 92 : 29-37.
PubMed
218 Mustafa RA, Wiercioch W, Arevalo-Rodriguez I, et al. Decision-making about healthcare related tests and diagnostic strategies : Paper 4 : International guidelines show variability in their approaches. J Clin Epidemiol. 2017 ; 92 : 38-46.
PubMed
219 Mustafa RA, Wiercioch W, Ventresca M, et al. Decision-making about healthcare related tests and diagnostic strategies : Paper 5 : a qualitative study with experts suggests that test accuracy data alone is rarely sufficient for decision-making. J Clin Epidemiol. 2017 ; 92 : 47-57.
PubMed
220 World Health Organisation : Commercial serodiagnostic tests for diagnosis of tuberculosis : Expert group meeting report 22 July 2010. (Available from http://whqlibdoc.who.int/hq/2011/WHO_HTM_TB_2011.14_eng.pdf)
 
221 Hsu J, Brozek JL, Terracciano L, et al. Application of GRADE : Making evidence based recommendations about diagnostic tests in clinical practice guidelines. Implementation Science. 2011 ; 6 : 62.
 
221 相原守夫, 訳. GRADEの適用 : 診療ガイドラインにおける診断検査に関して根拠に基づく推奨を作成する. 臨床評価. 2012 ; 40 : 199-212.
 
222 Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT : antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 ; 141 (2 Suppl) : e351S-e418S.
 
223 Singh S, Chang SM, Matchar DB, et al. Chapter 7 : grading a body of evidence on diagnostic tests. J Gen Intern Med. 2012 ; 27 Suppl 1 : S47-S55.
 
224 Spada C, Stoker J, Alarcon O, et al. Clinical indications for computed tomographic colonography : European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline. Endoscopy. 2014 ; 46 : 897-915.
PubMed
225 Mustafa RA, Wiercioch W, Santesso N, et al. Decision-Making about Healthcare Related Tests and Diagnostic Strategies : User Testing of GRADE Evidence Tables. PLoS One. 2015 ; 10 : e0134553.
PubMed
226 Crobach MJ, Planche T, Eckert C, et al. European Society of Clinical Microbiology and Infectious Diseases : update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016 ; 22 : Suppl 4 : S63-S81.
 
227 Fiocchi A, Brozek J, Schunemann H, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol. 2010 ; 21 Suppl 21 : 1-125.
 
228 Al-Hameed F, Al-Dorzi HM, Shamy A, et al. The Saudi clinical practice guideline for the diagnosis of the first deep venous thrombosis of the lower extremity. Ann Thorac Med. 2015 ; 10 : 3-15.
PubMed
229 Bossuyt PM, Irwig L, Craig J, et al. Comparative accuracy : assessing new tests against existing diagnostic pathways. BMJ. 2006 ; 332 : 1089-1092.
PubMed
230 Whiting PF, Weswood ME, Rutjes AW. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006 ; 6 : 9.
PubMed
231 Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2 : a revised tool for the quality assessment of diagnostic accuracy studies. Annals of internal medicine. 2011 ; 155 : 529-536.
PubMed
232 Minds QUADAS-2. (http://minds4.jcqhc.or.jp/minds/guideline/pdf/QUADAS-2_JPN.pdf)
 
233 小島原典子, 森實敏夫, 中山建夫, 他. 診断精度研究のバイアスリスク評価ツール QUADAS-2 : a Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies 2の活用. 薬理と治療. 2014 ; 42 : s127-s134.
 
234 Beach J, Rowe BH, Blitz S. et al. Diagnosis and management of work-related asthma. Evid Rep Technol Assess (Summ). 2005 ; 129 : 1-8.
PubMed
235 Virgili G, Menchini F, Dimastrogiovanni AF, et al. Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema : a systematic review. Invest Ophthalmol Vis Sci. 2007 ; 48 : 4963-4973.
PubMed
236 Holme O, Bretthauer M, Fretheim A, et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev. 2013 ; 9 : CD009259.
PubMed
237 Zamora J, Abraira V, Muriel A, et al. A. Meta-DiSc : a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006 ; 6 : 31.
PubMed
238 Harbord RM, Whiting P. metandi : Meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stata J. 2009 ; 9 : 211-229.
 
239 Dubourg J, Berhouma M, Cotton M, et al. Meta-analysis of diagnostic test accuracy in neurosurgical practice. Neurosurg Focus. 2012 ; 33 : E5.
PubMed
240 Liu Z, Yao Z, Li C, et al. A step-by-step guide to the systematic review and meta-analysis of diagnostic and prognostic test accuracy evaluations. Br J Cancer. 2013 ; 108 : 2299-2303.
 
241 Dwamena BA. MIDAS : Stata module for meta-analytical integration of diagnostic test accuracy studies. (http://ideas.repec.org/c/boc/bocode/s456880.html [accessed 2 October 2017])
 
242 Song J, Zhang J, Wang J, et al. Meta-analysis : narrow band imaging for diagnosis of gastric intestinal metaplasia. PLoS One. 2014 ; 9 : e94869.
 
243 Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005 ; 58 : 882-893.
PubMed
244 Sarigianni M, Liakos A, Vlachaki E, et al. Accuracy of magnetic resonance imaging in diagnosis of liver iron overload : a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015 ; 13 : 55-63. e5.
 
245 Malhotra RK. Chapter 7 : Samle size consideration for diagnostic test. Application to sensitivity and specificity. In : Doi SAR, Williams GM, ed. Methods of clinical epidemiology. Springer series on epidemiology and public health. Berlin Heidelberg ; Springer-Veerlag ; 2013.
 
246 Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR : a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology. 2007 ; 7 : 10.
PubMed
247 Kung J, Chiappelli F, Cajulis OO, et al. From Systematic Reviews to Clinical Recommendations for Evidence-Based Health Care : Validation of Revised Assessment of Multiple Systematic Reviews (R-AMSTAR) for Grading of Clinical Relevance. Open Dent J. 2010 ; 4 : 84-91.
PubMed
248 Pieper D, Buechter RB, Li L, et al. Systematic review found AMSTAR, but not R (evised) -AMSTAR, to have good measurement properties. J Clin Epidemiol. 2015 ; 68 : 574-583.
 
249 Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease : antithrombotic therapy and prevention of thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 ; 141 (2 Suppl) : e419S-e494S.
 
250 Plana MN, Abraira V, Zamora J. Chapter 8 : An introduction fo diagnostic meta-analysis. Doi SAR, Williams GM, ed. In : Methods of Clinical Epidemiology, Springer series on epidemiology and public health. Berlin Heidelberg : Springer-Veerlag ; 2013.
 
251 http://cran.r-project.org/web/packages/mada/index.html
 
252 McCarron CE, Pullenayegum EM, Thabane L, et al. Bayesian Hierarchical Models Combining Different Study Types and Adjusting for Covariate Imbalances : A Simulation Study to Assess Model Performance. PLoS One. 2011 ; 6 : e25635.
PubMed
253 Reitsma JB, Glas AS, Rutjes AWS, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005 ; 58 : 982-990.
PubMed
254 Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve : data-analytic approaches and some additional considerations. Stat Med. 1993 ; 12 : 1293-1316.
PubMed
255 Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports : a new meta-analytic method. Med Decis Making. 1993 ; 13 : 313-321.
PubMed
256 http://www2.napier.ac.uk/depts/fhls/diagmeta/
 
257 森實敏夫. 診断法のベイジアンメタアナリシス. あいみっく. 2013 ; 34 : 31-37.
 
258 Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988, 240 : 1285-1293.
PubMed
259 Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001 ; 20 : 2865-2884.
PubMed
260 http://www.nandinidendukuri.com/
 
261 http://training.cochrane.org/resource/cochrane-handbook-systematic-reviews-diagnostic-test-accuracy
 
262 http://netherlands.cochrane.org/sites/netherlands.cochrane.org/files/public/uploads/GRADE_workshop/GRADE%20Workshop%20hand-out.pdf
 
263 http://methods.cochrane.org/sites/methods.cochrane.org.sdt/files/public/uploads/MetaDAS%20Readme%20v1.3%20May%202012.pdf
 
264 森實敏夫. わかりやすい医学統計学. 東京 : メディカルトリビューン ; 2004.
 
265 森實敏夫. システマティックレビュー/メタアナリシスをめぐる国際的な状況とランダム効果モデルメタアナリシスの意義. あいみっく. 2012 ; 33 : 73-79.
 
266 Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes : methods for the absolute risk difference and relative risk scales. Stat Med. 2002 ; 21 : 1601-1623.
PubMed
267 Kalil AC, Sun J. Low-dose steroids for septic shock and severe sepsis : the use of Bayesian statistics to resolve clinical trial controversies. Intensive Care Med. 2011 ; 37 : 420-429.
PubMed
268 Doi SA, Barendregt JJ, Mozurkewich EL. Meta-analysis of heterogeneous clinical trials : an empirical example. Contemp Clin Trials. 2011 ; 32 : 288-298.
PubMed
269 http://www.epigear.com/index_files/metaxl.html
 
270 Doi SA, Barendregt JJ, Mozurkewich EL. Chapter 14 : Meta-analysis I. Computational methods. In : Doi SAR, Williams GM, ed. Methods of clinical epidemiology. Springer series on epidemiology and public health. Berlin Heidelberg : Springer-Veerlag ; 2013.
 
271 Hutton B, Salanti G, Caldwell DM, et al. . The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions : checklist and explanations. Ann Intern Med. 2015 ; 162 : 777-784.
PubMed
272 McInnes MDF, Moher D, Thombs BD et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies : The PRISMA-DTA Statement. JAMA. 2018 ; 319 : 388-396
 
273 Gopalakrishna G, Mustafa RA, Davenport C, et al. Applying Grading of Recommendations Assessment, Development and Evaluation (GRADE) to diagnostic tests was challenging but doable. J Clin Epidemiol. 2014 ; 67 : 760-768.
PubMed
274 Agoristsas T, Vandvik PO, Nermann I, et al. Finding current best evidence. In : Guyatt G, Rennie D, Meade MO, Cook DJ, eds. Users' guides to the medical literature-a manual for evidence-based clinical practice. 3rd ed. JAMAevidence. 2015 : 29-49.
 
275 https://www.sf-36.jp/qol/qol_top.html
 
276 平野吉子. 医療経済におけるQOL. 大阪府立大学経済研究. 2008 ; 53 : 139-155.
 

書評

最近チェックした商品履歴

Loading...